title: Treatment of acute, adverse psychedelic reactions: "I've tripped and I can't get down".
abstract: The resurgence of the use of LSD by a young, inexperienced population increases the likelihood of the occurrence of adverse psychedelic reactions. While the treatment of choice remains supportive, nonjudgmental talkdown, intramuscular lorazepam and haloperidol offer invaluable and specific adjuncts to care.
authors.affiliation: Haight Ashbury Free Medical Clinics, San Francisco, California.
authors.forename: P L
authors.initials: PL
authors.lastname: Miller
authors.forename: G R
authors.initials: GR
authors.lastname: Gay
authors.forename: K C
authors.initials: KC
authors.lastname: Ferris
authors.forename: S
authors.initials: S
authors.lastname: Anderson
mesh_terms: D000293:Adolescent; D000328:Adult; D004359:Drug Therapy, Combination; D006212:Hallucinations / Q000139:chemically induced / Q000188:drug therapy*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D008238:Lysergic Acid Diethylamide / Q000506:poisoning*; D008297:Male
chemical_list: D008238:Lysergic Acid Diethylamide; D006220:Haloperidol; D008140:Lorazepam